Is a cluster of brain cancers and brain tumors in a small village on the shores of an Illinois lake just a random occurrence, or can the cause of those illnesses be attributed to the negligence, even the recklessness, of a chemical company with a plant about a mile north of the village?
A Philadelphia jury has been selected to hear evidence in the trial of Branham v. Rohm & Haas Co., which is expected to last for eight to 10 weeks. The main issue in Branham is whether Rohm & Haas Co., the successive owner to Morton Chemical Co., is liable for Franklin Delano Branham’s fatal brain cancer. Philadelphia Common Pleas Judge Allan L. Tereshko is the presiding judge over the case.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]